ethics in psychopharmacology

Ethics in Psychopharmacology

As a future health psychology professional, you may be involved in assisting individuals with their treatment decisions and planning. It is important to not only assess the needs and circumstances unique to the individual, but also ensure you are fulfilling your professional and ethical standards.

Submit by Day 7 a 2- to 3-page paper that addresses the following:

Please use graphs or pics to help.

  • Using the information from the course and your own experiences, explain how you will approach the treatment decision-making process as a future health psychology professional. Explain how you might provide treatment planning and information to the client in a way that ensures comprehensive and informed personal choice.
  • Include analyses for working with individuals with dual diagnoses and individuals with cancer.
  • Include an analysis of why individuals with mental illness may self-medicate with drugs and alcohol.
  • Be sure to address issues of drug-drug interaction (DDI) as part of your analysis.

Support your Assignment with specific references to the Learning Resources and any additional references you used.

Readings

  • Advokat, C. D., & Comaty, J. E., & Julien, R. M. (2019). Julien’s primer of drug action: A comprehensive guide to the actions, uses, and side effects of psychoactive drugs (14th ed.). New York, NY: Worth Publishers/Macmillan.
    • Chapter 15, “Child and Adolescent Psychopharmacology” (pp. 572-609)
    • Chapter 17, “Challenging Times in Mental Health” (pp. 668-679)
  • Bruera, E., & Neumann, C. M. (1998). The uses of psychotropics in symptom management in advanced cancer. Psycho-Oncology, 7(4), 346–358.
    Retrieved from the Walden Library databases.
  • Buclin, T., Mazzocato, C., Berney, A., & Stiefel, F. (2001). Psychopharmacology in supportive care of cancer: A review for the clinician: IV. Other psychotropic agents. Supportive Care in Cancer, 9(4), 213–222.
    Retrieved from the Walden Library databases.
  • Cullivan, R., Crown, J., & Walsh, N. (1998). The use of psychotropic medication in patients referred to a psycho-oncology service. Psycho-Oncology, 7(4), 301–306.
    Retrieved from the Walden Library databases.
  • Stiefel, F., Bernery, A., & Mazzocato, C. (1999). Psychopharmacology in supportive care of cancer: A review for the clinician: I. Benzodiazepines. Supportive Care in Cancer, 7(6), 379–385.
    Retrieved from the Walden Library databases.
  • U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse. (2010). Comorbidity: Addiction and other mental illnesses (NIH Publication No. 10-5771). Retrieved from http://www.drugabuse.gov/publications/research-reports/comorbidity-addiction-other-mental-illnesses
  • U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health. (2013, January). How is depression treated in people who have cancer?Retrieved from http://www.nimh.nih.gov/health/publications/depression-and-cancer/how-is-depression-treated-in-people-who-have-cancer.shtml
  • U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health. (2013, March). Which groups have special needs when taking psychiatric medications?Retrieved from http://www.nimh.nih.gov/health/publications/mental-health-medications/which-groups-have-special-needs-when-taking-psychiatric-medications.shtml

Media

  • Robinson, G. E. (2012, January 27). Psychopharmacology in pregnancy and post partum [Video file]. Retrieved from http://www.veomed.com/va021770682012
    Psychopharmacology in Pregnancy and Post Partum [Video] by Gail Robinson. 2012. Used with permission of Gail Robinson.